THC
18.6–21.9%
CBD
0.4%
Brazilian Seed Company's Early Chemo tests between 19 and 21 percent THC, solidly upper-middle for a hybrid.
No effect, terpene, flavor or medical-use data specific to Early Chemo has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
21.9% THC
About Early Chemo
Brazilian Seed Company's Early Chemo tests between 19 and 21 percent THC, a solidly strong hybrid reading that sits comfortably in upper-middle territory. No terpene analysis, flavor panel, or effect data has been documented for this cut, so the potency figure and the seed company behind it make up what's currently verifiable. The Chemo-family name traces back to a well-known diesel-adjacent lineage in cannabis breeding lore, though without confirmed parentage on this specific listing, that association can't be treated as established fact here. Brazilian Seed Company's involvement at least offers a known source to reference, which may matter more to some growers than the potency number alone. As with several other entries from this catalog, the THC range currently outpaces the documented sensory detail, leaving plenty of room for someone to fill in the rest through direct experience.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Early Chemo
Is Early Chemo an Indica, Sativa, or Hybrid?
Early Chemo is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Early Chemo?
Early Chemo: 21.9% THC and 0.4% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.